{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:49:42Z","timestamp":1790628582993,"version":"4.1.0"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>JOURNAL\/nrgr\/04.03\/01300535-202602000-00048\/figure1\/v\/2026-04-22T115157Z\/r\/image-tiff<\/jats:p>\n                  <jats:p>\n                    Diabetic retinopathy is a prominent cause of blindness in adults, with early retinal ganglion cell loss contributing to visual dysfunction or blindness. In the brain, defects in \u03b3-aminobutyric acid synaptic transmission are associated with pathophysiological and neurodegenerative disorders, whereas glucagon-like peptide-1 has demonstrated neuroprotective effects. However, it is not yet clear whether diabetes causes alterations in inhibitory input to retinal ganglion cells and whether and how glucagon-like peptide-1 protects against neurodegeneration in the diabetic retina through regulating inhibitory synaptic transmission to retinal ganglion cells. In the present study, we used the patch-clamp technique to record \u03b3-aminobutyric acid subtype A receptor\u2013mediated miniature inhibitory postsynaptic currents in retinal ganglion cells from streptozotocin-induced diabetes model rats. We found that early diabetes (4 weeks of hyperglycemia) decreased the frequency of GABAergic miniature inhibitory postsynaptic currents in retinal ganglion cells without altering their amplitude, suggesting a reduction in the spontaneous release of \u03b3-aminobutyric acid to retinal ganglion cells. Topical administration of glucagon-like peptide-1 eyedrops over a period of 2 weeks effectively countered the hyperglycemia-induced downregulation of GABAergic mIPSC frequency, subsequently enhancing the survival of retinal ganglion cells. Concurrently, the protective effects of glucagon-like peptide-1 on retinal ganglion cells in diabetic rats were eliminated by topical administration of exendin-9-39, a specific glucagon-like peptide-1 receptor antagonist, or SR95531, a specific antagonist of the \u03b3-aminobutyric acid subtype A receptor. Furthermore, extracellular perfusion of glucagon-like peptide-1 was found to elevate the frequencies of GABAergic miniature inhibitory postsynaptic currents in both ON- and OFF-type retinal ganglion cells. This elevation was shown to be mediated by activation of the phosphatidylinositol-phospholipase C\/inositol 1,4,5-trisphosphate receptor\/Ca\n                    <jats:sup>2+<\/jats:sup>\n                    \/protein kinase C signaling pathway downstream of glucagon-like peptide-1 receptor activation. Moreover, multielectrode array recordings revealed that glucagon-like peptide-1 functionally augmented the photoresponses of ON-type retinal ganglion cells. Optomotor response tests demonstrated that diabetic rats exhibited reductions in visual acuity and contrast sensitivity that were significantly ameliorated by topical administration of glucagon-like peptide-1. These results suggest that glucagon-like peptide-1 facilitates the release of \u03b3-aminobutyric acid onto retinal ganglion cells through the activation of glucagon-like peptide-1 receptor, leading to the de-excitation of retinal ganglion cell circuits and the inhibition of excitotoxic processes associated with diabetic retinopathy. Collectively, our findings indicate that the \u03b3-aminobutyric acid system has potential as a therapeutic target for mitigating early-stage diabetic retinopathy. Furthermore, the topical administration of glucagon-like peptide-1 eyedrops represents a non-invasive and effective treatment approach for managing early-stage diabetic retinopathy.\n                  <\/jats:p>","DOI":"10.4103\/nrr.nrr-d-24-00001","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T08:05:28Z","timestamp":1719475528000},"page":"800-810","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Topical administration of GLP-1 eyedrops improves retinal ganglion cell function by facilitating presynaptic GABA release in early experimental diabetes"],"prefix":"10.4103","volume":"21","author":[{"given":"Yu-Qi","family":"Shao","sequence":"first","affiliation":[{"name":"State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang-Ze","family":"Ruan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Feng","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti-Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jun","family":"Weng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong-Li","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-2655","authenticated-orcid":false,"given":"Yong-Mei","family":"Zhong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1523\/JNEUROSCI.1607-04.2004","article-title":"Glucagon-like peptide 1 excites hypocretin\/orexin neurons by direct and indirect mechanisms: Implications for viscera-mediated arousal","volume":"24","author":"Acuna-Goycolea","year":"2004","journal-title":"J Neurosci"},{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11892-007-0056-9","article-title":"GLP-1-based therapy of type 2 diabetes: GLP\u20131 mimetics and DPP-IV inhibitors","volume":"7","author":"Ahr\u00e9n","year":"2007","journal-title":"Curr Diab Rep"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.exer.2019.04.014","article-title":"Pregabalin affords retinal neuroprotection in diabetic rats: Suppression of retinal glutamate, microglia cell expression and apoptotic cell death","volume":"184","author":"Ali","year":"2019","journal-title":"Exp Eye Res"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archopht.1997.01100160331011","article-title":"Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy","volume":"115","author":"Ambati","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R5-20260422","article-title":"ARVO Statement for the Use of Animals in Ophthalmic and Vision Research","year":"2021"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1523\/JNEUROSCI.3483-13.2014","article-title":"Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes","volume":"34","author":"Aung","year":"2014","journal-title":"J Neurosci"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.visres.2017.06.014","article-title":"Neurodegeneration in diabetic retinopathy: Potential for novel therapies","volume":"139","author":"Barber","year":"2017","journal-title":"Vision Res"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF00173582","article-title":"A role for protein kinase C in the electrically evoked release of [3H] gamma-aminobutyric acid in rabbit caudate nucleus","volume":"339","author":"Bartmann","year":"1989","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1016\/S0021-9258(19)85156-6","article-title":"The nature of protein kinase C activation by physically defined phospholipid vesicles and diacylglycerols","volume":"260","author":"Boni","year":"1985","journal-title":"J Biol Chem"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.7150\/ijms.20962","article-title":"GLP-1 treatment improves diabetic retinopathy by alleviating autophagy through GLP-1R-ERK1\/2-HDAC6 signaling pathway","volume":"14","author":"Cai","year":"2017","journal-title":"Int J Med Sci"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1523\/JNEUROSCI.15-02-01249.1995","article-title":"Presynaptic enhancement of inhibitory synaptic transmission by protein kinases A and C in the rat hippocampus in vitro","volume":"15","author":"Capogna","year":"1995","journal-title":"J Neurosci"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.exer.2017.07.010","article-title":"Retinal exposure to high glucose condition modifies the GABAergic system: Regulation by nitric oxide","volume":"162","author":"Carpi-Santos","year":"2017","journal-title":"Exp Eye Res"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuropharm.2009.07.027","article-title":"GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders","volume":"57","author":"Charych","year":"2009","journal-title":"Neuropharmacology"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroscience.2007.09.015","article-title":"Hyperpolarization-activated cation current is involved in modulation of the excitability of rat retinal ganglion cells by dopamine","volume":"150","author":"Chen","year":"2007","journal-title":"Neuroscience"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1167\/iovs.18-26359","article-title":"ON-type retinal ganglion cells are preferentially affected in STZ-induced diabetic mice","volume":"60","author":"Cui","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bjo.69.2.136","article-title":"Impaired contrast sensitivity in diabetic patients with and without retinopathy: A new technique for rapid assessment","volume":"69","author":"Della Sala","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2337\/diab.46.4.615","article-title":"Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide","volume":"46","author":"Ding","year":"1997","journal-title":"Diabetes"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1017\/S0952523805225166","article-title":"Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system","volume":"22","author":"Douglas","year":"2005","journal-title":"Vis Neurosci"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"E006","DOI":"10.1017\/S095252382000005X","article-title":"The effects of early diabetes on inner retinal neurons","volume":"37","author":"Eggers","year":"2020","journal-title":"Vis Neurosci"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.exer.2014.05.004","article-title":"Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats","volume":"127","author":"Fan","year":"2014","journal-title":"Exp Eye Res"},{"key":"R21-20260422","first-page":"1557","article-title":"Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2\/Bax and Bcl-xL\/Bax ratios and reducing reactive gliosis","volume":"20","author":"Fan","year":"2014","journal-title":"Mol Vis"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fncel.2016.00214","article-title":"Glucagon-like peptide-1 excites firing and increases GABAergic miniature postsynaptic currents (mPSCs) in gonadotropin-releasing hormone (GnRH) neurons of the male mice via activation of nitric oxide (NO) and suppression of endocannabinoid signaling pathways","volume":"10","author":"Farkas","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/neuro.02.005.2008","article-title":"Epilepsy, E\/I balance and GABA(A) receptor plasticity","volume":"1","author":"Fritschy","year":"2008","journal-title":"Front Mol Neurosci"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1469-7793.2000.t01-1-00629.x","article-title":"GABA release from mouse axonal growth cones","volume":"3","author":"Gao","year":"2000","journal-title":"J Physiol 523 Pt"},{"key":"R25-20260422","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1167\/iovs.07-0683","article-title":"Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice","volume":"49","author":"Gastinger","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-20260422","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"R27-20260422","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0042-6989(98)00169-2","article-title":"Behavioural visual acuity of wild type and bcl2 transgenic mouse","volume":"39","author":"Gianfranceschi","year":"1999","journal-title":"Vision Res"},{"key":"R28-20260422","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02576216","article-title":"Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas","volume":"193","author":"G\u00f6ke","year":"1993","journal-title":"Res Exp Med (Berl)"},{"key":"R29-20260422","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/dom.13339","article-title":"Glucagon-like peptide-1 receptor expression in the human eye","volume":"20","author":"Hebsgaard","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"R30-20260422","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db15-0443","article-title":"Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes","volume":"65","author":"Hern\u00e1ndez","year":"2016","journal-title":"Diabetes"},{"key":"R31-20260422","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s00125-017-4388-y","article-title":"Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes","volume":"60","author":"Hern\u00e1ndez","year":"2017","journal-title":"Diabetologia"},{"key":"R32-20260422","first-page":"1","article-title":"Alteration of the GABAergic neuronal system of the retina and superior colliculus in streptozotocin-induced diabetic rat","volume":"44","author":"Honda","year":"1998","journal-title":"Kobe J Med Sci"},{"key":"R33-20260422","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/02713689609017612","article-title":"Changes in GABA metabolism in streptozotocin-induced diabetic rat retinas","volume":"15","author":"Ishikawa","year":"1996","journal-title":"Curr Eye Res"},{"key":"R34-20260422","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archopht.1990.01070050070033","article-title":"Electrophysiological changes in juvenile diabetics without retinopathy","volume":"108","author":"Juen","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"R35-20260422","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0898-6568(02)00074-8","article-title":"Signalling specificity in GPCR-dependent Ca2+ signalling","volume":"15","author":"Kiselyov","year":"2003","journal-title":"Cell Signal"},{"key":"R36-20260422","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2337\/db14-0668","article-title":"GLP-1 and exendin-4 transiently enhance GABAA receptor-mediated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons","volume":"64","author":"Korol","year":"2015","journal-title":"Diabetes"},{"key":"R37-20260422","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neuropharm.2017.11.015","article-title":"Glucagon-like Peptide-1 (GLP-1) and neurotransmitters signaling in epilepsy: An insight review","volume":"136","author":"Koshal","year":"2018","journal-title":"Neuropharmacology"},{"key":"R38-20260422","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0197-0186(00)00112-1","article-title":"Retinal glutamate in diabetes and effect of antioxidants","volume":"38","author":"Kowluru","year":"2001","journal-title":"Neurochem Int"},{"key":"R39-20260422","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00417-006-0506-0","article-title":"Oscillatory potentials and the b-wave: Partial masking and interdependence in dark adaptation and diabetes in the rat","volume":"245","author":"Layton","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R40-20260422","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/dc15-2171","article-title":"Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010","volume":"39","author":"Leasher","year":"2016","journal-title":"Diabetes Care"},{"key":"R41-20260422","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/exer.2002.1170","article-title":"Early retinal damage in experimental diabetes: electroretinographical and morphological observations","volume":"74","author":"Li","year":"2002","journal-title":"Exp Eye Res"},{"key":"R42-20260422","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroscience.2015.08.008","article-title":"Orexin-A potentiates L-type calcium\/barium currents in rat retinal ganglion cells","volume":"305","author":"Liu","year":"2015","journal-title":"Neuroscience"},{"key":"R43-20260422","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1167\/iovs.09-4069","article-title":"Correlation between retinal oscillatory potentials and retinal vascular caliber in type 2 diabetes","volume":"51","author":"Luu","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R44-20260422","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0301-0082(98)00017-3","article-title":"Protein kinase C: a physiological mediator of enhanced transmitter output","volume":"55","author":"Majewski","year":"1998","journal-title":"Prog Neurobiol"},{"key":"R45-20260422","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nn0901-877","article-title":"The fundamental plan of the retina","volume":"4","author":"Masland","year":"2001","journal-title":"Nat Neurosci"},{"key":"R46-20260422","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuron.2012.10.002","article-title":"The neuronal organization of the retina","volume":"76","author":"Masland","year":"2012","journal-title":"Neuron"},{"key":"R47-20260422","doi-asserted-by":"crossref","first-page":"109279","DOI":"10.1016\/j.exer.2022.109279","article-title":"Synaptotagmins 1 and 7 in vesicle release from rods of mouse retina","volume":"225","author":"Mesnard","year":"2022","journal-title":"Exp Eye Res"},{"key":"R48-20260422","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.exer.2013.07.026","article-title":"Regulation of GABA content by glucose in the chick retina","volume":"115","author":"Miya-Coreixas","year":"2013","journal-title":"Exp Eye Res"},{"key":"R49-20260422","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1042\/BC20040149","article-title":"Sigma-1 receptor as regulator of neuronal intracellular Ca2+: Clinical and therapeutic relevance","volume":"97","author":"Monnet","year":"2005","journal-title":"Biol Cell"},{"key":"R50-20260422","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1167\/iovs.15-17999","article-title":"Early retinal neuronal dysfunction in diabetic mice: Reduced light-evoked inhibition increases rod pathway signaling","volume":"57","author":"Moore-Dotson","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R51-20260422","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1523\/JNEUROSCI.16-21-06713.1996","article-title":"A SNARE complex containing syntaxin 3 is present in ribbon synapses of the retina","volume":"16","author":"Morgans","year":"1996","journal-title":"J Neurosci"},{"key":"R52-20260422","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST0331341","article-title":"Regulation of exocytosis by protein kinase C","volume":"33","author":"Morgan","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"R53-20260422","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1523\/JNEUROSCI.23-14-06063.2003","article-title":"Light-evoked excitatory and inhibitory synaptic inputs to ON and OFF alpha ganglion cells in the mouse retina","volume":"23","author":"Pang","year":"2003","journal-title":"J Neurosci"},{"key":"R54-20260422","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.3.3.6","article-title":"Rodent hyperglycemia-induced inner retinal deficits are mirrored in human diabetes","volume":"3","author":"Pardue","year":"2014","journal-title":"Transl Vis Sci Technol"},{"key":"R55-20260422","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000316042","article-title":"Peak density and distribution of ganglion cells in the retinae of microchiropteran bats: Implications for visual acuity","volume":"32","author":"Pettigrew","year":"1988","journal-title":"Brain Behav Evol"},{"key":"R56-20260422","doi-asserted-by":"crossref","first-page":"36150","DOI":"10.1155\/2007\/36150","article-title":"A role for excitatory amino acids in diabetic eye disease","volume":"2007","author":"Pulido","year":"2007","journal-title":"Exp Diabetes Res"},{"key":"R57-20260422","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/antiox9090846","article-title":"Beneficial effects of glucagon-like peptide-1 (GLP-1) in diabetes-induced retinal abnormalities: involvement of oxidative stress","volume":"9","author":"Ramos","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"R58-20260422","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/biomedicines9121772","article-title":"Neuromodulation induced by sitagliptin: A new strategy for treating diabetic retinopathy","volume":"9","author":"Ramos","year":"2021","journal-title":"Biomedicines"},{"key":"R59-20260422","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3390\/antiox11071418","article-title":"Antioxidant effects of DPP-4 inhibitors in early stages of experimental diabetic retinopathy","volume":"11","author":"Ramos","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"R60-20260422","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"R61-20260422","doi-asserted-by":"crossref","first-page":"108492","DOI":"10.1016\/j.neuropharm.2021.108492","article-title":"Orexin-A differentially modulates inhibitory and excitatory synaptic transmission in rat inner retina","volume":"187","author":"Ruan","year":"2021","journal-title":"Neuropharmacology"},{"key":"R62-20260422","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1476-5381.2012.01971.x","article-title":"Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders","volume":"166","author":"Salcedo","year":"2012","journal-title":"Br J Pharmacol"},{"key":"R63-20260422","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/jcm8030339","article-title":"New insights into the mechanisms of action of topical administration of GLP-1 in an experimental model of diabetic retinopathy","volume":"8","author":"Sampedro","year":"2019","journal-title":"J Clin Med"},{"key":"R64-20260422","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1152\/jn.00558.2013","article-title":"Genetic disruption of the On visual pathway affects cortical orientation selectivity and contrast sensitivity in mice","volume":"111","author":"Sarnaik","year":"2014","journal-title":"J Neurophysiol"},{"key":"R65-20260422","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00109-017-1508-6","article-title":"A role of PLC\/PKC-dependent pathway in GLP-1-stimulated insulin secretion","volume":"95","author":"Shigeto","year":"2017","journal-title":"J Mol Med (Berl)"},{"key":"R66-20260422","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2019.04.018","article-title":"Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R\/Akt\/GSK3\u03b2 signaling","volume":"153","author":"Shu","year":"2019","journal-title":"Neuropharmacology"},{"key":"R67-20260422","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"R68-20260422","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0896-6273(03)00389-1","article-title":"Visual stimulation is required for refinement of ON and OFF pathways in postnatal retina","volume":"39","author":"Tian","year":"2003","journal-title":"Neuron"},{"key":"R69-20260422","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0039-6257(99)00063-6","article-title":"The electroretinogram in diabetic retinopathy","volume":"44","author":"Tzekov","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"R70-20260422","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1167\/iovs.12-10825","article-title":"Loss of scotopic contrast sensitivity in the optomotor response of diabetic mice","volume":"54","author":"Umino","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R71-20260422","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/BF02532391","article-title":"Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium","volume":"21","author":"Vilchis","year":"1996","journal-title":"Neurochem Res"},{"key":"R72-20260422","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/cns.12150","article-title":"Upregulation of glutamate-aspartate transporter by glial cell line-derived neurotrophic factor ameliorates cell apoptosis in neural retina in streptozotocin-induced diabetic rats","volume":"19","author":"Wang","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"R73-20260422","doi-asserted-by":"crossref","first-page":"107680","DOI":"10.1016\/j.isci.2023.107680","article-title":"Exendin-4 promotes retinal ganglion cell survival and function by inhibiting calcium channels in experimental diabetes","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"key":"R74-20260422","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1152\/jn.00604.2005","article-title":"Calcium from internal stores triggers GABA release from retinal amacrine cells","volume":"94","author":"Warrier","year":"2005","journal-title":"J Neurophysiol"},{"key":"R75-20260422","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0748730409343767","article-title":"Circadian modulation of melanopsin-driven light response in rat ganglion-cell photoreceptors","volume":"24","author":"Weng","year":"2009","journal-title":"J Biol Rhythms"},{"key":"R76-20260422","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/cne.20389","article-title":"Rat retinal dopaminergic neurons: Differential maturation of somatodendritic and axonal compartments","volume":"481","author":"Witkovsky","year":"2005","journal-title":"J Comp Neurol"},{"key":"R77-20260422","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-023-01137-8","article-title":"Assessment of visual function in blind mice and monkeys with subretinally implanted nanowire arrays as artificial photoreceptors","author":"Yang","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"R78-20260422","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000326784","article-title":"\u03c3 receptor 1 is preferentially involved in modulation of N-methyl-D-aspartate receptor-mediated light-evoked excitatory postsynaptic currents in rat retinal ganglion cells","volume":"19","author":"Zhang","year":"2011","journal-title":"Neurosignals"},{"key":"R79-20260422","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1167\/iovs.09-4727","article-title":"Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats","volume":"52","author":"Zhang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-24-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:47:52Z","timestamp":1787773672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-24-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/nrr.nrr-d-24-00001","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"2024-01-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}